Hebei Changshan Biochemical Pharmaceutical (300255.SZ) announced that the company recently received a notification from shareholder Mr. Yang Minghuan regarding the shareholding...
According to the announcement from Hebei Changshan Biochemical Pharmaceutical (300255.SZ) on the Zhitong Finance and Economics app, the company recently received a notification from shareholder Mr. Yang Minghuan regarding the completion of the implementation of the shareholding reduction plan. The aforementioned shareholding reduction plan was completed on November 26, 2024, with a total reduction of 9.190457 million shares, representing a reduction ratio of 0.99998%.